Education
Efficacy, Safety and Patient Experiences of Rhenium-SCT® for Non-Melanoma Skin Cancer
To read the full published manuscript, visit: https://www.advancesradonc.org/article/S2452-1094(25)00089-2/fulltext
Rhenium-Skin Cancer Therapy with Dr Joe Cardaci and A/Prof Kurt Gebauer
Medical Forum’s clinical editor, Dr Joe Kosterich, sits down with leading nuclear medicine specialist Dr Joe Cardaci and dermatologist A/Prof Kurt Gebauer to discuss Rhenium-SCT.
Vumedi Educational Webinar with Dr Sid Baxi
Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Non-Melanoma Skin Cancer: Interim Results From the EPIC-Skin Study.
Modelling Rhenium-SCT® Dose Distributions Using Monte Carlo Methods: A Foundational Dosimetry Study
In the radiation oncology setting, clinicians and medical physicists are familiar with the fundamentals of radiation therapy and dosimetry; particularly regarding the interaction of X-rays, electrons, and radioisotope sources within human tissue, as seen in treatments like external beam radiation therapy and brachytherapy.
